A new JDRF International-funded study of a drug called verapamil is offering exciting new potential for a path to keeping beta cells healthier for longer in people with type 1 diabetes (T1D).When a person is diagnosed with T1D, they still have some remaining beta cells that continue to insulin for a few months – known […]
The causes of type 1 diabetes (T1D) are complex and not fully understood. What is known is that there is a genetic component to developing T1D – but who is at greater risk? JDRF Canada is pleased to announce a new JDRF grant to support Dr. Despoina Manousaki, pediatric endocrinologist and genetic epidemiologist at Sainte-Justine […]
A significant part of JDRF Canada’s research strategy is funding the most promising cure-based research for type 1 diabetes (T1D). T1D is an autoimmune disease where the body destroys the cells in the pancreas responsible for making insulin. People with T1D must administer external sources of insulin, either through multiple daily injections, pump or pen […]
Every two years, more than 160 children living with type 1 diabetes (T1D) gather in Washington, D.C., to meet face-to-face with some of the top decision-makers in the U.S. government. Similar to Kids for a Cure, the youth delegates in JDRF’s Children’s Congress take advantage of this once-in-a-lifetime opportunity to help US Members of Congress […]
A newly re-tooled third-party fundraising program is now available across Canada: JDRF Your Way. Support. Participate. Fundraise… Your Way JDRF’s foundations lie in grassroots efforts and fundraising, and our accomplishments as an organization can be traced back to the power of our incredible community. In 1974, four years after JDRF was founded in the United States, […]
As we got through the height of the pandemic in 2021 and moved into 2022, we believed that it would be a year of hope. And thanks to the support of our incredible community of donors, volunteers, supporters – we surpassed even our wildest expectations. We opened the year with one of our biggest undertakings […]
It’s the holiday season, and for most people that means indulging in seasonal treats and meals. It’s no different for people living with type 1 diabetes (T1D). One of the major stresses of managing T1D, particularly for people who are newly diagnosed can be meal planning, and both how it will affect blood glucose levels […]
In November, to celebrate World Diabetes Day, the BETTER (BEhaviors, Therapies, TEchnologies and hypoglycemic Risk in Type 1 diabetes) project announced that it is now the first registry of people living with type 1 diabetes in Canada. A key focus of JDRF’s research strategy is to fund research that can improve the lives of people […]
JDRF’s Kids For a Cure advocacy event was held from November 13- 15 in Ottawa and what an impact our youth delegates made – engaging with more than 55 Members of Parliament and Senators during 20 meetings to share their stories of what it means to live with type 1 diabetes (T1D) and advocate the […]
A diagnosis of type 1 diabetes (T1D) changes the trajectory of an entire family. This was no different for the Turner Family when Alex was diagnosed at 14-years-old. The Turners are a close-knit family, parents Richard and Alison, and children Alex, Sara and Emma approached Alex’s diagnosis together as a family. “At 14 years old, […]
December 2021 marked the launch of the JDRF Centre of Excellence at the University of British Columbia (UBC). One year later, a team of over 40 researchers convened in person at UBC for the first annual meeting to review and celebrate progress, translate knowledge, engage with the type 1 diabetes (T1D) community, and discuss what […]
This is the first therapeutic on the market that may help delay the onset of clinicaltype 1 diabetes November 17, 2022 Today, the U.S. Food and Drug Administration (FDA) weighed the evidence for teplizumab to delay type 1 diabetes (T1D) in at-risk individuals, and the T1D community got a big win: Approved! Teplizumab (Provention Bio […]
